Arax Advisory Partners’s Shattuck Labs STTK Stock Holding History

Arax Advisory Partners’s Portfolio STTK Stock Details STTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-14	Closed	-$33	–	4511
2025 Q3	$33	Buy	+14	New	+$17	﹤0.01%	3553

Other funds holding STTK

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

NCM

NEXTBio Capital Management Menlo Park, California $215M AUM

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CEI

Clark Estates Inc New York $416M AUM 6.04% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Arax Advisory Partners's STTK Position: Q4 2025 in Review

Arax Advisory Partners sold out of Shattuck Labs (STTK) in Q4 2025, closing a stake of 14 shares — an estimated $33 sold.

Arax Advisory Partners first reported a position in STTK in Q3 2025 and held it in 1 quarter. The position peaked at $33 in Q3 2025. 65 funds tracked by Wall St. Rank hold STTK as of Q4 2025.

Arax Advisory Partners reported no remaining Shattuck Labs position as of Q4 2025 after selling out during the quarter.
Arax Advisory Partners sold 14 Shattuck Labs shares in Q4 2025, an estimated $33.
Arax Advisory Partners first reported a position in Shattuck Labs in Q3 2025 and held it in 1 quarter.
Arax Advisory Partners's Shattuck Labs position peaked at $33 in Q3 2025.
65 funds tracked by Wall St. Rank held Shattuck Labs as of Q4 2025.

Based on Arax Advisory Partners's 13F filing for Q4 2025, filed 13 Feb 2026.